Legal Status of Traditional Medicine and Complementary/Alternative Medicine: A Worldwide Review
Author: World Health Organization
Date Published: 2001
National policies are the basis for defining the role of traditional and complementary/alternative medicine in national health care programs, ensuring that the necessary regulatory and legal mechanisms are created for promoting and maintaining good practice; assuring authenticity, safety and efficacy of traditional and complementary/alternative therapies; and providing equitable access to health care resources and information about those resources.This document provides information on the legal status of traditional and complementary/alternative medicine in a number of countries. It is intended to facilitate the development of legal frameworks and the sharing of experiences between countries by introducing what some countries have done in terms of regulating traditional and complementary/alternative medicine. This information will be beneficial not only to policy-makers, but also to researchers, universities, the public, insurance companies and pharmaceutical industries.
Date Published: 2001
National policies are the basis for defining the role of traditional and complementary/alternative medicine in national health care programs, ensuring that the necessary regulatory and legal mechanisms are created for promoting and maintaining good practice; assuring authenticity, safety and efficacy of traditional and complementary/alternative therapies; and providing equitable access to health care resources and information about those resources.This document provides information on the legal status of traditional and complementary/alternative medicine in a number of countries. It is intended to facilitate the development of legal frameworks and the sharing of experiences between countries by introducing what some countries have done in terms of regulating traditional and complementary/alternative medicine. This information will be beneficial not only to policy-makers, but also to researchers, universities, the public, insurance companies and pharmaceutical industries.
